Hendrik Nolte, MD, PhD, David I

Slides:

Advertisements

Similar presentations

Double-Blind Placebo-Controlled Trial of Dapsone in Antihistamine Refractory Chronic Idiopathic Urticaria Matt Morgan, MD, Andrew Cooke, MD, Laura Rogers,

Advertisements

The Journal of Allergy and Clinical Immunology: In Practice

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD

Advances in Diagnosing Peanut Allergy

Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: Pooled analyses Stephen R. Durham,

Oral Phenylephrine HCl for Nasal Congestion in Seasonal Allergic Rhinitis: A Randomized, Open-label, Placebo-controlled Study Eli O. Meltzer, MD, Paul.

Justin R. Chen, MD, Scott A. Tarver, PharmD, Kristin S

Aleena Banerji, MD, Kimberly G. Blumenthal, MD, MSc, Kenneth H

Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: Pooled analyses Stephen R. Durham,

Vitamin D Insufficiency and Asthma in a US Nationwide Study

Auvi-Q Versus EpiPen: Preferences of Adults, Caregivers, and Children

Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults Peter S. Creticos, MD, Jennifer Maloney,

Chronic rhinosinusitis: Potential new use for topical sulfasalazine

Dennis K. Ledford, MD, Sally Wenzel, MD

Network Meta-analysis Shows Commercialized Subcutaneous and Sublingual Grass Products Have Comparable Efficacy Harold Nelson, MD, Shannon Cartier, MSc,

Effective treatment of house dust mite–induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled.

Desensitization to Chemotherapeutic Agents

Intramuscular Versus Intravenous Immunoglobulin Replacement Therapy and Measurement of Immunoglobulin Levels During Immunoglobulin Replacement Therapy

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD

The effects of house dust mite sublingual immunotherapy tablet on immunologic biomarkers and nasal allergen challenge symptoms Natasha C. Gunawardana,

Clinical Management of Food Allergy

A Multicenter Observational Study of US Adults with Acute Asthma: Who Are the Frequent Users of the Emergency Department? Kohei Hasegawa, MD, MPH, Ashley.

An Infant with Atopic Dermatitis and Itching After Ingestion of Milk

Robert G. Hamilton, PhD, John Oppenheimer, MD

Validation of the Pregnancy Asthma Control Test

Reply Journal of Allergy and Clinical Immunology

Recall Urticaria in Adalimumab Hypersensitivity

Practice Notes from the AAAAI

The Mastocytosis Society Survey on Mast Cell Disorders: Patient Experiences and Perceptions Susan Jennings, PhD, Nancy Russell, DrPH, Blair Jennings,

Advances in Diagnosing Peanut Allergy

Timothy J. Craig, DO, H. Henry Li, MD, Marc Riedl, MD, Jonathan A

Nonadherence to Asthma Treatment: Getting Unstuck

Impact of Adverse Event Solicitation on the Safety Profile of SQ House Dust Mite Sublingual Immunotherapy Tablet Hendrik Nolte, MD, PhD, David I. Bernstein,

Peter M. Wolfgram, MD, David B. Allen, MD

Successful treatment of idiopathic angioedema with ecallantide

House Dust Mite Respiratory Allergy: An Overview of Current Therapeutic Strategies Moisés A. Calderón, MD, PhD, Jörg Kleine-Tebbe, MD, Allan Linneberg,

Aimee L. Speck, MD, Michael Hess, MSI, Alan P. Baptist, MD, MPH

Management of Difficult-to-Treat Atopic Dermatitis

Pitfalls and peculiarities in chlorhexidine allergy

Repeated Episodes of Anaphylaxis with Normal Serum Tryptase but Elevated Levels of Urinary Prostaglandin D2 Phillip Lieberman, MD The Journal of Allergy.

Penicillin Skin Testing Is a Safe and Effective Tool for Evaluating Penicillin Allergy in the Pediatric Population Stephanie J. Fox, MD, Miguel A. Park,

Reply Journal of Allergy and Clinical Immunology

Phillip Lieberman, MD, Michael Tankersley, MD

News & Notes Journal of Allergy and Clinical Immunology

Double-Blind Placebo-Controlled Trial of Dapsone in Antihistamine Refractory Chronic Idiopathic Urticaria Matt Morgan, MD, Andrew Cooke, MD, Laura Rogers,

The Management of Eosinophilic Esophagitis

Phillip Lieberman, MD, David Golden, MD

Sequential Treatment Initiation with Timothy Grass and Ragweed Sublingual Immunotherapy Tablets Followed by Simultaneous Treatment Is Well Tolerated

Anaphylactic Reaction to White-Faced Hornet Sting and Elevated Baseline (Asymptomatic) Serum Tryptase Phillip Lieberman, MD, Lawrence B. Schwartz, MD,

Linda S. Cox, MD, Cheryl Hankin, PhD, Richard Lockey, MD

Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial Hendrik.

Neetu Talreja, MD, Richard F. Lockey, MD

Mapping the Asthma Care Process: Implications for Research and Practice Alexandra Lelia Dima, PhD, Marijn de Bruin, PhD, Eric Van Ganse, MD, PhD, FRCP

Sharon Seth, MD, David A. Khan, MD

Cephalosporin Side Chain Cross-reactivity

Evaluation of Allergen Immunotherapy

News & Notes Journal of Allergy and Clinical Immunology

Two ideas to improve mite allergen avoidance

Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment

House dust mite sublingual immunotherapy: Results of a US trial

Impact of Adverse Event Solicitation on the Safety Profile of SQ House Dust Mite Sublingual Immunotherapy Tablet Hendrik Nolte, MD, PhD, David I. Bernstein,

Reply The Journal of Allergy and Clinical Immunology: In Practice

News Beyond Our Pages Journal of Allergy and Clinical Immunology

Efficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite–induced allergic.

Clinical Management of Atopic Dermatitis: Practical Highlights and Updates from the Atopic Dermatitis Practice Parameter 2012 Peter A. Lio, MD, Margaret.

Footnotes1 Journal of Allergy and Clinical Immunology

Pedro Giavina-Bianchi, MD, PhD, Shih-Wen Huang, MD

Effect of grass sublingual tablet immunotherapy is similar in children and adults: A Bayesian approach to design pediatric sublingual immunotherapy trials

News & Notes Journal of Allergy and Clinical Immunology

News Beyond Our Pages Journal of Allergy and Clinical Immunology

Presentation transcript:

Treatment with the SQ house dust mite sublingual immunotherapy tablet may be initiated year-round Hendrik Nolte, MD, PhD, David I. Bernstein, MD, FAAAAI, Jörg Kleine-Tebbe, MD, FAAAAI, Peter A. Fejerskov, RN, BSN, Qing Li, PhD, Susan Lu, PharmD, Harrold S. Nelson, MD, FAAAAI The Journal of Allergy and Clinical Immunology: In Practice Volume 6, Issue 5, Pages 1758-1760.e1 (September 2018) DOI: 10.1016/j.jaip.2017.12.035 Copyright © 2018 ALK Abelló A/S Terms and Conditions

Figure 1 Placebo-subtracted frequencies of TEAEs (A), TRAEs (B), local site reactions (C), and asthma-related AEs by season (D). The Journal of Allergy and Clinical Immunology: In Practice 2018 6, 1758-1760.e1DOI: (10.1016/j.jaip.2017.12.035) Copyright © 2018 ALK Abelló A/S Terms and Conditions

Figure 2 Placebo-subtracted frequencies of TRAEs by season for monosensitized and polysensitized subjects initiating treatment with the SQ-HDM SLIT tablet in spring (A) or summer (B). The Journal of Allergy and Clinical Immunology: In Practice 2018 6, 1758-1760.e1DOI: (10.1016/j.jaip.2017.12.035) Copyright © 2018 ALK Abelló A/S Terms and Conditions